Clinical Trial Is First of Its Kind
Tilray-sponsored research looking at the effectiveness of CBD and THC in essential tremor is moving ahead.
University of California researchers are conducting the first double-blind, placebo-control clinical trial of cannabis in an oral capsule.
“Patients with ET have long reported tremor benefits with the use of cannabis.”
It says although no controlled trials have been conducted (until now), patients with ET have long reported tremor benefits with the use of cannabis.”
According to a recently updated clinical trial record, the study started in early 2019 and is expected to be completed in September 2020.
In September 2018, Tilray announced it had received approval from the U.S. Drug Enforcement Administration to import a medical cannabis product into the United States from Canada for “a clinical trial at the University of California San Diego Center for Medicinal Cannabis Research.”
Essential tremor affects up to 1% of the population and up to 5% of people over the age of 65. The tremor most often affect the hands, head, voice and legs.